Individuals Coming Off Weight-Loss Jabs Gain Back Pounds Far More Rapidly Than People Using Diet and Exercise

Fresh analysis indicates that people who stop using new slimming jabs like Mounjaro or Wegovy may regain shed pounds far faster than those who end traditional diet and exercise plans.

Published data in a leading health publication shows that while overweight individuals often shed about a fifth of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month once they quit.

"Users purchasing such medications should be aware of the danger of rapid rebound weight gain when the therapy ends," stated researcher Dr. Susan Jebb.

This pace of regain means a return to starting weight within about one and a half years.

Comparing Therapies

The analysis, which examined dozens of trials involving thousands of patients, compared the effects of these new drugs with older methods.

Scientists emphasize that people who lose weight through lifestyle changes alone usually see a more gradual weight regain—approximately 0.1 kg a month—after stopping.

The Reason for the Rapid Rebound

Doctors propose the mechanism of the injections is key to understanding the accelerated rebound.

These medications imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 levels several times higher than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication leads to appetite is unsuppressed, making overeating a significant risk."

A Lifelong Disease?

The NHS suggest the injections for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.

Many experts say that, due to the significant potential of weight regain, the therapy should be considered ongoing.

This view is reinforced by pharmaceutical companies, who state that the results "highlight the long-term character of excess weight," similar to managing conditions like diabetes.

Patient Accounts

Users who have stopped the medication explain a intense resurgence of cravings.

"I experienced a trigger that goes on and you're instantly ravenous," described a patient.

This difficulty is compounded if users have not adopted sustainable dietary or behavioural changes during treatment.

Significant Adoption

Figures indicate that millions of people in the UK have used these injections in the past year, with demand being substantial.

• Use is greater among women than men.
• The 40s and 50s age group shows the highest usage rates.
• Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, experts emphasize that while GLP-1 drugs are powerful tools for weight loss, they are not a magic cure and lasting health benefits relies on integrated behavioural management.